Wyss InstituteWomen’s Health – Wyss Institute

The Wyss Institute’s 2026-2027 Validation Projects

Jessica Leff — Mon, 06 Jul 2026 14:00:41 +0000

Each year, the Wyss Institute’s Validation Project program identifies technologies that are ready to move beyond the discovery and into the validation phase. Through dedicated funding, technical resources, business development support, market research, and engagement with clinicians, investors, industry experts, and key opinion leaders, the program helps research teams de-risk high-impact…

Source

Machine-learning how to overcome antibiotic-resistant gonorrhea

Jessica Leff — Wed, 17 Jun 2026 17:55:26 +0000

By Benjamin Boettner (BOSTON) — With tens of millions of annual cases, gonorrhea is the second most frequently reported sexually transmitted infection (STI). In the U.S. alone, over 600,000 cases are reported each year. If left untreated, gonorrhea can result in severe reproductive health issues, including infertility in both women and men, and pelvic inflammatory disease.

Source

Multidisciplinary Wyss team receives 2026 Lush Prize Science Award

Jessica Leff — Mon, 18 May 2026 18:30:48 +0000

(BOSTON) — The Wyss Institute for Biologically Inspired Engineering at Harvard University is proud to announce that the Biosensing, Microfluidics, and Microsystems team, led by Wyss Senior Engineer Adama Sesay, Ph.D., together with the Female Reproductive Health team, has received the 2026 Lush Science Prize. The prize recognizes their work developing next-generation, sensor-integrated human Organ…

Source

Help Advance Women’s Health Research

Jessica Leff — Mon, 06 Apr 2026 19:40:42 +0000

Endometriosis affects millions worldwide. Diagnosis can take 7 to 10 years and often relies on invasive surgery. The FemSmaht Research Team at the Wyss Institute is working to change that. We are conducting a study to develop a non-invasive method for detecting endometriosis and we are looking for menstruating individuals (endometriosis-positive and those without endometriosis) to help move this…

Source

Unravel: from tools for studying pathogen tolerance to hope for rare disease patients

Jessica Leff — Thu, 20 Nov 2025 17:49:56 +0000

Part of the Wyss Institute’s series on the positive, life-altering impact of federal research funding By Jessica Leff There are approximately 350 million people in the world with a rare disease, including 25-30 million Americans. About 80% of the disorders are genetic, and 95% of them have no FDA-approved treatments. Finding an effective drug is no small task; after an expensive and long…

Source

How federal funds fuel life-saving innovation

Jessica Leff — Thu, 20 Nov 2025 17:49:40 +0000

Source

Wyss Institute receives Wellcome Leap funding to develop first Human Organ Chip model for heavy menstrual bleeding

Jessica Leff — Fri, 19 Sep 2025 13:55:11 +0000

By Alexandra Jirstrand (BOSTON) – The Wyss Institute for Biologically Inspired Engineering at Harvard University has been awarded funding from Wellcome Leap’s $50 million The Missed Vital Sign program, which seeks to transform how menstruation is understood and treated in healthcare. The Wyss will use its pioneering Organ Chip technology to create the first human model of heavy menstrual…

Source

The Wyss Institute’s 2025-2026 Validation Projects

Jessica Leff — Thu, 14 Aug 2025 15:00:53 +0000

Throughout recent years, the Wyss’ Validation Project mechanism has proven to be a highly valuable instrument for selecting and kick-starting projects with early potential for positive impact on healthcare and the environment. Reaching deep into areas with major unmet needs across the diverse Grand Challenges laid out by the Institute, the newly selected projects are driven by multi-talented teams…

Source

ENDOx: Reimagining Endometriosis Care Through Precision Nanomedicine

admin — Tue, 29 Jul 2025 20:12:37 +0000

Endometriosis is characterized by the abnormal growth of tissue resembling the endometrium outside the uterus. It is estimated to affect 10–15% of reproductive-aged women and is associated with significant morbidity, including chronic pelvic pain and infertility. With no curative treatments currently available, standard therapies rely on hormonal suppression or invasive surgery, both of which are…

Source

The Tipping Point for Women’s Health

Mariel Schoen — Mon, 23 Jun 2025 14:00:29 +0000

Last month, the Wyss Institute had the honor of hosting the Women’s Health Access Matters (WHAM) Spring Forum, convening researchers, industry leaders, investors, and advocates committed to closing the gender health gap. The event brought together cross-sector voices to explore bold ideas, share scientific breakthroughs, and catalyze action across women’s brain, heart, and reproductive health.

Source